MX394882B - Derivados de imidazo[1,5-a]pirazina como inhibidores de fosfatidilinositol-4,5-bisfosfato 3-quinasadelta (pi3kdelta) - Google Patents

Derivados de imidazo[1,5-a]pirazina como inhibidores de fosfatidilinositol-4,5-bisfosfato 3-quinasadelta (pi3kdelta)

Info

Publication number
MX394882B
MX394882B MX2019006612A MX2019006612A MX394882B MX 394882 B MX394882 B MX 394882B MX 2019006612 A MX2019006612 A MX 2019006612A MX 2019006612 A MX2019006612 A MX 2019006612A MX 394882 B MX394882 B MX 394882B
Authority
MX
Mexico
Prior art keywords
kinasadelta
bisphosphato
pi3kdelta
phosphatidylinositol
imidazo
Prior art date
Application number
MX2019006612A
Other languages
English (en)
Spanish (es)
Other versions
MX2019006612A (es
Inventor
Haibo Zhao
Jing Li
Zhiwei Wang
Original Assignee
Beigene Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beigene Ltd filed Critical Beigene Ltd
Publication of MX2019006612A publication Critical patent/MX2019006612A/es
Publication of MX394882B publication Critical patent/MX394882B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MX2019006612A 2016-12-07 2017-12-07 Derivados de imidazo[1,5-a]pirazina como inhibidores de fosfatidilinositol-4,5-bisfosfato 3-quinasadelta (pi3kdelta) MX394882B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2016108897 2016-12-07
PCT/CN2017/114970 WO2018103688A1 (en) 2016-12-07 2017-12-07 IMIDAZO [1,5-A] PYRAZINE DERIVATIVES AS PI3Kdelta INHIBITORS

Publications (2)

Publication Number Publication Date
MX2019006612A MX2019006612A (es) 2019-08-01
MX394882B true MX394882B (es) 2025-03-24

Family

ID=62491736

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019006612A MX394882B (es) 2016-12-07 2017-12-07 Derivados de imidazo[1,5-a]pirazina como inhibidores de fosfatidilinositol-4,5-bisfosfato 3-quinasadelta (pi3kdelta)

Country Status (16)

Country Link
US (2) US11136323B2 (cg-RX-API-DMAC10.html)
EP (1) EP3551630A4 (cg-RX-API-DMAC10.html)
JP (2) JP7064495B2 (cg-RX-API-DMAC10.html)
KR (1) KR20190091339A (cg-RX-API-DMAC10.html)
CN (2) CN114805366A (cg-RX-API-DMAC10.html)
AU (2) AU2017372377B2 (cg-RX-API-DMAC10.html)
BR (1) BR112019011847A2 (cg-RX-API-DMAC10.html)
CA (1) CA3045959A1 (cg-RX-API-DMAC10.html)
EA (1) EA201991355A1 (cg-RX-API-DMAC10.html)
IL (2) IL266986B (cg-RX-API-DMAC10.html)
MX (1) MX394882B (cg-RX-API-DMAC10.html)
NZ (1) NZ754944A (cg-RX-API-DMAC10.html)
SG (1) SG10201912192RA (cg-RX-API-DMAC10.html)
TW (2) TWI762534B (cg-RX-API-DMAC10.html)
WO (1) WO2018103688A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA201903286B (cg-RX-API-DMAC10.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX394882B (es) 2016-12-07 2025-03-24 Beigene Ltd Derivados de imidazo[1,5-a]pirazina como inhibidores de fosfatidilinositol-4,5-bisfosfato 3-quinasadelta (pi3kdelta)
NZ761680A (en) * 2017-09-08 2023-03-31 Beigene Ltd Imidazo[1,5-a]pyrazine derivatives as pi3kdelta inhibitors
US20230011916A1 (en) * 2019-11-21 2023-01-12 Beigene, Ltd. Methods of cancer treatment using anti-ox40 antibodies in combination with pi3 kinase delta inhibitors
KR102344185B1 (ko) * 2020-02-26 2021-12-27 계명대학교 산학협력단 신규한 Pim 키나아제 억제제 및 이의 용도
JP2024521763A (ja) * 2021-05-27 2024-06-04 ベイジーン スウィッツァーランド ゲーエムベーハー Pi3kデルタ阻害剤の塩、その結晶形態、調製方法、及び使用
TW202327611A (zh) * 2021-09-14 2023-07-16 英屬開曼群島商百濟神州有限公司 使用btk抑制劑和p13激酶抑制劑的組合治療癌症之方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2372694T3 (es) * 2003-10-15 2012-01-25 OSI Pharmaceuticals, LLC Inhibidores de tirosina cinasa de imidazo[1,5-a]pirazina.
NZ596185A (en) * 2009-04-16 2013-01-25 Ct Nac Investigaciones Oncologicas Cnio Imidazopyrazines for use as kinase inhibitors
US8653089B2 (en) 2011-02-09 2014-02-18 F. Hoffmann-La Roche Ag Heterocyclic compounds and methods of use
CA2860723A1 (en) * 2012-01-10 2013-07-18 Bayer Intellectual Property Gmbh Substituted imidazopyrazines as akt kinase inhibitors
RU2702908C2 (ru) 2012-11-01 2019-10-14 Инфинити Фармасьютикалз, Инк. Лечение злокачественных опухолей с использованием модуляторов изоформ pi3-киназы
KR20160013204A (ko) * 2013-05-30 2016-02-03 인피니티 파마슈티칼스, 인코포레이티드 Pi3 키나아제 동형단백질 조절제를 사용하는 암의 치료
WO2015058084A1 (en) 2013-10-18 2015-04-23 Medivation Technologies, Inc. Heterocyclic compounds and methods of use
SMT202100674T1 (it) 2014-08-11 2022-01-10 Acerta Pharma Bv Combinazioni terapeutiche di un inibitore di btk e un inibitore di bcl-2
MX394882B (es) 2016-12-07 2025-03-24 Beigene Ltd Derivados de imidazo[1,5-a]pirazina como inhibidores de fosfatidilinositol-4,5-bisfosfato 3-quinasadelta (pi3kdelta)
NZ761680A (en) 2017-09-08 2023-03-31 Beigene Ltd Imidazo[1,5-a]pyrazine derivatives as pi3kdelta inhibitors

Also Published As

Publication number Publication date
IL266986A (en) 2019-07-31
SG10201912192RA (en) 2020-02-27
ZA201903286B (en) 2021-01-27
JP7064495B2 (ja) 2022-05-10
TW202233190A (zh) 2022-09-01
AU2022203737A1 (en) 2022-06-23
NZ754944A (en) 2023-02-24
US11725012B2 (en) 2023-08-15
MX2019006612A (es) 2019-08-01
US20220098202A1 (en) 2022-03-31
EP3551630A4 (en) 2020-07-15
IL290419B (en) 2022-10-01
IL266986B (en) 2022-03-01
WO2018103688A1 (en) 2018-06-14
EP3551630A1 (en) 2019-10-16
JP2022090051A (ja) 2022-06-16
CA3045959A1 (en) 2018-06-14
CN110267959B (zh) 2022-05-27
TWI762534B (zh) 2022-05-01
KR20190091339A (ko) 2019-08-05
TW201833113A (zh) 2018-09-16
EA201991355A1 (ru) 2019-11-29
IL290419B2 (en) 2023-02-01
AU2017372377A1 (en) 2019-07-18
JP2020500909A (ja) 2020-01-16
US11136323B2 (en) 2021-10-05
CN114805366A (zh) 2022-07-29
AU2017372377B2 (en) 2022-03-03
CN110267959A (zh) 2019-09-20
IL290419A (en) 2022-04-01
BR112019011847A2 (pt) 2019-10-29
US20190367523A1 (en) 2019-12-05

Similar Documents

Publication Publication Date Title
MX2020007265A (es) Derivados de rapamicina.
CO2022001094A2 (es) Pirrolo[2,3-b]pirazinas como inhibidores de hpk1 y uso de las mismas
MX386089B (es) Compuesto heterociclico utilizado como inhibidor de fgfr.
MX2024009886A (es) Derivados de quinolina como inhibidores de integrina alfa4beta7.
GEP20207105B (en) 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2yl carbamate derivatives as magl inhibitors
SA520411843B1 (ar) Trpc6 مشتقات بيريدين كربونيل والاستخدام الطبي لها كمثبطات
CR20220182A (es) Pirimidin-2-ilamino-1h-pirazoles como inhibidores de lrrk2 para el uso en el tratamiento de trastornos neurodegenerativos (divisional 2018-592)
EA201691058A1 (ru) Производные пирролопирролона и их применение для лечения заболеваний
EA201992126A1 (ru) Ингибиторы jak, содержащие 4-членный гетероциклический амид
EA201592256A1 (ru) Производные имидазопирролидинона и их применение при лечении заболеваний
MX2021010122A (es) Compuestos de imidazopiridinilo y su uso para el tratamiento de trastornos neurodegenerativos.
SG10201902206QA (en) Radiolabelled derivatives of a 2-amino-6-fluoro-n-[5-fluoro-pyridin-3-yl]- pyrazolo[1,5-a]pyrimidin-3-carboxamide compound useful as atr kinase inhibitor, the preparation of said compound and different solid forms thereof
EA201592250A1 (ru) Пиразолопирролидиновые производные и их применение в лечение заболеваний
EA201790246A1 (ru) Гетероциклические карбоновые кислоты в качестве активаторов растворимой гуанилатциклазы
NZ754944A (en) Imidazo [1,5-a] pyrazine derivatives as pi3kdelta inhibitors
EA201691428A1 (ru) Бициклические гетероциклические производные в качестве ингибиторов irak4
MX387443B (es) Compuestos de heteroarilcarboxamida como inhibidores de ripk2
EA201791802A1 (ru) СШИТЫЕ ДИГИДРО-4H-ПИРАЗОЛО[5,1-c][1,4]ОКСАЗИНИЛОВЫЕ СОЕДИНЕНИЯ И АНАЛОГИ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ ЦНС
MX2021007247A (es) Derivados de rapamicina.
MX376283B (es) Compuestos de imidazopiridazina.
MX2020002630A (es) Derivados de imidazo[1,5-a]pirazina como inhibidores de fosfatidilinositol-4,5-bisfosfato 3-quinasadelta.
EA201790253A1 (ru) Ингибиторы альдостеронсинтазы
EA201692300A1 (ru) Производные карбоксамида
EA201790830A1 (ru) Ингибиторы альдостеронсинтазы
CY1121060T1 (el) Παραγωγα [1,2,4] τριαζολο[1,5-α] πυριμιδινης ως αναστολεις πρωτεασωματος πρωτοζωων για τη θεραπεια παρασιτικων νοσηματων οπως η λεϊσμανιαση